$0.24
0.00 (0%)
Favrille, Inc. (FVRL)
CAPS Rating:
A biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system.
Recs
0
weird...couldnt resist...like staring at an accident.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 1 of 1